Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study.

Dana M ChaseSoham ShuklaJulia MooreTirza Areli Calderón BoyleJonathan LimJessica PerhanidisJean A HurteauJeanne M Schilder

Published in: Oncology and therapy (2024)

This real-world, retrospective, observational analysis offers valuable insights on prognostic factors associated with TTNT in patients with OC treated with 1LM niraparib monotherapy after first-line platinum-based chemotherapy. Future studies are needed to examine how additional patient characteristics associated with clinical outcomes may guide treatment decisions and improve outcomes.

Keyphrases

combination therapy
computed tomography
cross sectional
randomized controlled trial
squamous cell carcinoma
magnetic resonance
adipose tissue
open label
radiation therapy
current status
positron emission tomography
dual energy